Cannabis
Search documents
Village Farms International to Report Q4 and Full Year 2025 Results on March 12, 2026
Globenewswire· 2026-02-26 21:30
Company Overview - Village Farms International, Inc. is a large-scale, vertically-integrated supplier of high-value, high-growth plant-based Consumer Packaged Goods, leveraging decades of experience in Controlled Environment Agriculture [4] - The company has a strong foundation as a leading fresh produce supplier in the US and Canada, while now focusing on high-growth cannabinoid opportunities internationally [4] Cannabis Operations - In Canada, the company's subsidiary, Pure Sunfarms, operates one of the largest cannabis facilities globally, with 2.2 million square feet of greenhouse production, and is recognized as a low-cost producer with high-quality products [5] - Village Farms owns an additional 2.6 million square feet of greenhouse capacity in Canada for future expansion and holds an 80% stake in Rose LifeScience, a leader in cannabis product commercialization [5] International Expansion - The company is targeting legal cannabis opportunities internationally, exporting medical cannabis from its EU GMP certified facility in Canada to markets such as Germany, the UK, Israel, Australia, and New Zealand [6] - Village Farms is expanding its export business and making investments in international production assets, including a license to grow and distribute recreational cannabis in the Netherlands [6] US Market Strategy - In the US, Balanced Health Botanicals, a wholly-owned subsidiary, is a leading CBD and hemp-derived brand and e-commerce platform [7] - Village Farms plans to enter the US THC market by leveraging its Texas-based greenhouse assets, which include 2.2 million square feet of existing greenhouse capacity and 950 acres of owned land for future expansion [7] Renewable Energy Initiatives - Village Farms Clean Energy, in partnership with Terreva Renewables, generates renewable natural gas from landfill gas at its Delta RNG facility, receiving royalties on all generated revenue [8]
Curaleaf Reports Fourth Quarter and Full Year 2025 Results: Domestic and International Growth Accelerate with Gross Margin Expansion
Prnewswire· 2026-02-26 21:01
[https://ir.curaleaf.com].Curaleaf IR X Account: [https://x.com/Curaleaf_IR]Investor Relations Website: [https://ir.curaleaf.com/]Contact Information:Investor Contact: Curaleaf Holdings, Inc.Camilo Lyon, Chief Investment Officer [[email protected]]Media Contact:MATTIO Communications [[email protected]]DisclaimerThis press release contains "forward-looking information" and "forward-looking statements" within the meaning of Canadian securities laws and securities laws of the U.S. (together, "forward- looking ...
The Federal Reserve faces impossible math as gold signals approaching debt wall
KITCO· 2026-02-26 16:44
Jeremy Szafron joins Kitco News as an anchor and producer from Kitco’s Vancouver bureau. Jeremy is a seasoned journalist with a diverse background covering entertainment, current affairs and finance. Jeremy began his career in 2006 as a Journalist at CTV (Canada’s largest network), initially engaging audiences as an entertainment reporter before pivoting to business reporting focusing on mining and small-caps. His macro-financial and market trends analysis made him a sought-after commentator on CTV Mornin ...
XSW: I Like This Beaten-Up Tech ETF
Seeking Alpha· 2026-02-26 16:17
Alan Brochstein, CFA has been contributing articles to Seeking Alpha since 2007. He has worked on the sell-side and the buy-side in fixed-income and on the buy-side in equities. Alan got his start as a financial professional in the securities industry in 1986 after earning a B.A. in Economics and in Mathematical Methods in the Social Sciences from Northwestern University. He was managing investments in institutional environments until he founded AB Analytical Services in 2007 to provide independent consulti ...
3 Top Marijuana Stocks to Watch Before March 2026
Marijuana Stocks | Cannabis Investments And News. Roots Of A Budding Industry.™· 2026-02-26 15:00
Industry Overview - The U.S. cannabis industry is evolving as it approaches 2026, with growth being uneven but still presenting opportunities [1] - Operators are focusing on efficiency and profitability, while investors are monitoring federal reform progress [1][2] - Rescheduling discussions have improved overall sentiment, but capital access remains limited for many companies [1] Market Dynamics - Leading multi-state operators are building scale, with strong retail footprints providing steady revenue streams [2] - Brand development is crucial for defending margins as competition tightens, making operational discipline critical [2] - Stability is a priority for investors, with balance sheet strength and positive adjusted EBITDA trends being more important than rapid expansion [3] Key Markets - Florida, Illinois, Pennsylvania, and Ohio are identified as key battleground states with strong consumer demand [3] - Pricing pressure continues in mature regions, making scale and branding competitive advantages [3] Notable Companies - Ascend Wellness Holdings is refining operations and focusing on efficiency, with annual revenue in the half-billion-dollar range and positive adjusted EBITDA trends [4][9][10] - Cansortium, operating under the FLUENT brand, is focused on Florida and maintains a vertically integrated structure, with recent strategic moves improving its balance sheet [11][14][15] - Cresco Labs is one of the largest U.S. multi-state operators, with a broad footprint and strong brand presence, generating annual revenue exceeding several hundred million dollars [16][18][20] Financial Performance - Ascend has reported fluctuating quarterly revenue due to pricing pressure but has shown improvement in adjusted EBITDA margins [9] - Cansortium's revenue reflects industry volatility, but cost reductions have supported adjusted EBITDA stability [14] - Cresco has consistently maintained positive adjusted EBITDA, with liquidity improving following balance sheet adjustments [19]
Cronos Group(CRON) - 2025 Q4 - Earnings Call Transcript
2026-02-26 14:32
Cronos Group (NasdaqGM:CRON) Q4 2025 Earnings call February 26, 2026 08:30 AM ET Company ParticipantsAnna Shlimak - CFOHarrison Aaron - Senior Director of Investor Relations and Corporate DevelopmentMike Gorenstein - Chairman, President, and CEORyan Neal - Equity Research AssociateConference Call ParticipantsBill Kirk - Managing Director and Senior Research AnalystKendrick Tai - Equity Research Analyst of Cannabis and Consumer GrowthPablo Zuanic - Founder, Managing Partner, and Equity Research Analyst of Ca ...
Cronos Group(CRON) - 2025 Q4 - Earnings Call Transcript
2026-02-26 14:32
Cronos Group (NasdaqGM:CRON) Q4 2025 Earnings call February 26, 2026 08:30 AM ET Company ParticipantsAnna Shlimak - CFOHarrison Aaron - Senior Director of Investor Relations and Corporate DevelopmentMike Gorenstein - Chairman, President, and CEORyan Neal - Equity Research AssociateConference Call ParticipantsBill Kirk - Managing Director and Senior Research AnalystKendrick Tai - Equity Research Analyst of Cannabis and Consumer GrowthPablo Zuanic - Founder, Managing Partner, and Equity Research Analyst of Ca ...
Cannara Announces Graduation to the Toronto Stock Exchange
Globenewswire· 2026-02-26 13:00
MONTREAL, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. (“Cannara”, “the Company”, “us” or “we”) (TSXV: LOVE) (OTCQX: LOVFF) (FRA: 8CB0), a vertically integrated producer of premium-grade cannabis products at affordable prices with two mega facilities based in Québec spanning over 1,600,000 sq. ft., is pleased to announce that it has received final approval to graduate (the "Uplisting") from the TSX Venture Exchange to the Toronto Stock Exchange (the "TSX"). "Graduating to the TSX represents a sign ...
Cronos Group Reports 2025 Fourth Quarter and Full-Year Results
Globenewswire· 2026-02-26 12:35
Core Insights - Cronos Group Inc. achieved record net revenue in Q4 2025 and FY 2025, with Q4 revenue increasing by 47% year-over-year to $44.5 million and FY revenue increasing by 25% year-over-year to $146.6 million [1][2][16] - The company reported strong performance driven by consumer demand, expansion at Cronos GrowCo, and contributions from international markets [2][3] - The company maintains a robust balance sheet with $832 million in cash and cash equivalents and short-term investments [1] Financial Performance - Q4 2025 net revenue of $44.5 million increased by $14.2 million from Q4 2024, primarily due to higher cannabis flower sales in Israel and other countries [10] - Gross profit for Q4 2025 was $16.2 million, an increase of $5.4 million from Q4 2024, driven by higher average sales prices and sales volumes [10] - For FY 2025, gross profit reached $62.8 million, up $37.6 million from FY 2024, attributed to lower inventory step-up costs and higher sales prices [16] Brand and Market Position - The Spinach brand maintained a strong position in Canada, ranking 2 overall and 4 in the flower category with a market share of 5.1% [11] - SOURZ by Spinach led the edibles category with a market share of 21.7% in Q4 2025, continuing to innovate with new product launches [12] - PEACE NATURALS consistently ranked as the top cannabis brand in Israel, achieving record sales volume and revenue throughout 2025 [15] International Expansion - The PEACE NATURALS brand expanded into new international markets, including Australia, Malta, and Switzerland, significantly increasing its global footprint [17] - International revenue outside Israel grew by 68% year-over-year in Q4 2025, reflecting strong demand and normalized shipment timing [17] Strategic Acquisition - Cronos Group entered into an agreement to acquire CanAdelaar B.V. for approximately $67 million, which will enhance its strategic footprint in Europe and leverage its borderless product strategy [22][24] - CanAdelaar operates a significant greenhouse facility and has rapidly grown its market share in the Dutch cannabis market, achieving net revenue of $47.3 million in the twelve months ended September 30, 2025 [23] Operational Updates - The company reported a net loss of $0.5 million in Q4 2025, a significant decrease from net income of $43.9 million in Q4 2024, primarily due to foreign currency transaction losses [10] - Adjusted EBITDA for FY 2025 improved by $45.1 million to $10.1 million, driven by higher adjusted gross profit and lower operating expenses [16]
Good Supply Cannabis Brand Expands High-Potency Portfolio with New Spring Lineup Across Canada
Globenewswire· 2026-02-26 12:00
TORONTO, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company at the forefront of the cannabis, beverage and wellness industries, today announced that Good Supply, one of Canada’s most recognized cannabis brands, has launched its spring product lineup, a new seasonal product release designed to accelerate growth across high-performing formats, including high-potency vapes, flower, and expanded pre-roll offerings. Good Supply’ ...